Odyssey Therapeutics Uk Limited
11609778
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 06/10/2021
CEO
AMERICAN · UNITED STATES · Age 65
Also on 1 other board
director · Since 06/10/2021
FOUNDER AND GLOBAL CO-HEAD
AMERICAN · UNITED STATES · Age 61
director · Since 12/03/2024
ODYSSEY UK HEAD OF OPERATIONS LONDON
AUSTRALIAN · ENGLAND · Age 41
Persons with Significant Control
Odyssey Therapeutics Inc.
PO BOX 8386 Ann Arbor, Ann Arbor, Ann Arbor
Reg: N/A · Delaware · Delaware Corporation
Notified 06/10/2021
Former PSCs
Mr Edward Nikolas Grant
Ceased 06/10/2021
Mr Leonard Peter Wossnig
Ceased 06/10/2021
CompanyRankvs 12686+ SIC 62012 peers67
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£118
Balance sheet strength
Cash
£124k
Cash in the bank
Net Current Assets
£4.0M
Working capital
Current Assets
£4.2M
Current Liabilities
£130k
Debtors
£4.1M
Profit After Tax
£214k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2024 | 32.14 |
| 2023 | 15.60 |
| 2022 | 10.44 |
| 2021 | 45.45 |
| 2020 | 134.77 |
| 2019 | 146.80 |
Derived from filed accounts. Not audited figures.